2-(1-萘基)乙烷磺酰氯 | 104296-63-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 中文名称: 2-(1-萘基)乙烷磺酰氯
• 中文别名: 2-(1-萘基)乙基磺酰氯
• 英文名称: 2-(1-naphthyl)ethanesulfonyl chloride
• 英文别名: 2-naphthalen-1-ylethanesulfonyl chloride
• CAS: 104296-63-1
• 化学式: C₁₂H₁₁ClO₂S
• 分子量: 254.737
• InChiKey: IAZQBUVCHCLINF-UHFFFAOYSA-N

物化性质

• 熔点：
  50 °C
• 溶解度：
  微溶于甲苯

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  42.5
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  8
• 安全说明：
  S26
• 危险类别码：
  R34
• 海关编码：
  2904909090
• 危险品运输编号：
  UN 3261

SDS

---

Section I.Chemical Product and Company Identification
Chemical Name 2-(1-Naphthyl)ethanesulfonyl Chloride
Portland OR
1-Naphthaleneethanesulfonyl Chloride
Synonym
C12H11ClO2S
Chemical Formula
CAS Number 104296-63-1

---

Section II. Composition and Information on Ingredients
Chemical Name CAS Number Percent (%) TLV/PEL Toxicology Data
2-(1-Naphthyl)ethanesulfonyl Chloride 104296-63-1 Min. 97.0 Not available. Not available.
(Tit.)

---

Section III. Hazards Identification
Acute Health Effects Corrosive to skin, eyes, and respiratory system. Liquid or spray mist may produce tissue damage, particularly in mucous
membranes of the eyes, mouth and respiratory tract. Skin contact may produce burns. Eye contact can result in corneal
damage or blindness. Inhalation of the spray mist may produce severe irritation of respiratory tract, characterized by
coughing, choking, or shortness of breath. Corrosive materials may cause serious injury if ingested.
Harmful if ingested or inhaled. Minimize exposure to this material. Severe overexposure can result in injury or death.
Follow safe industrial hygiene practices and always wear proper protective equipment when handling this compound.
CARCINOGENIC EFFECTS : Not available.
Chronic Health Effects
MUTAGENIC EFFECTS : Not available.
TERATOGENIC EFFECTS : Not available.
DEVELOPMENTAL TOXICITY: Not available.
Repeated exposure of the eyes to a low level of dust can produce eye irritation. Repeated skin exposure can produce
local skin destruction, or dermatitis. Repeated inhalation of dust can produce varying degree of respiratory irritation or
lung damage.

---

Section IV. First Aid Measures
Eye Contact Check for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15
minutes. Get medical attention.
Skin Contact In case of contact, immediately flush skin with plenty of water. Remove contaminated clothing and shoes. Wash clothing
before reuse. Thoroughly clean shoes before reuse. Get medical attention.
Inhalation If the victim is not breathing, perform mouth-to-mouth resuscitation. Loosen tight clothing such as a collar, tie, belt or
waistband. If breathing is difficult, oxygen can be administered. Seek medical attention if respiration problems do not
improve.
Ingestion DO NOT INDUCE VOMITING. Loosen tight clothing such as a collar, tie, belt or waistband. If the victim is not breathing,
perform mouth-to-mouth resuscitation. Examine the lips and mouth to ascertain whether the tissues are damaged, a
possible indication that the toxic material was ingested; the absence of such signs, however, is not conclusive.

---

Section V. Fire and Explosion Data
Auto-Ignition Not available.
Flammability May be combustible at high temperature.
Flash Points Flammable Limits Not available.
Not available.
Combustion Products These products are toxic carbon oxides (CO, CO2), sulfur oxides (SOx), halogenated compounds.
WARNING: Highly toxic HCl gas is produced during combustion.
Fire Hazards
Not available.
Explosion Hazards Risks of explosion of the product in presence of mechanical impact: Not available.
Risks of explosion of the product in presence of static discharge: Not available.
Fire Fighting Media
SMALL FIRE: Use DRY chemical powder.
LARGE FIRE: Use water spray, fog or foam. DO NOT use water jet.
and Instructions
Consult with local fire authorities before attempting large scale fire-fighting operations.
Continued on Next Page
2-(1-Naphthyl)ethanesulfonyl Chloride

---

Section VI. Accidental Release Measures
Spill Cleanup Corrosive material. Harmful material.
Stop leak if without risk. DO NOT get water inside container. DO NOT touch spilled material. Use water spray to reduce
Instructions
vapors. Prevent entry into sewers, basements or confined areas; dike if needed. Eliminate all sources of ignition.
Consult federal, state, and/or local authorities for assistance on disposal.

---

Section VII. Handling and Storage
Handling and Storage CORROSIVE. HARMFUL. REFRIGERATE. Keep container dry. Keep away from heat. Mechanical exhaust required.
When not in use, tightly seal the container and store in a dry, cool place. Avoid excessive heat and light. Do not breathe
Information
dust. Never add water to this product. Wear suitable protective clothing. If you feel unwell, seek medical attention and
show the label when possible. Treat symptomatically and supportively.
Always store away from incompatible compounds such as oxidizing agents, alkalis (bases).

---

Section VIII. Exposure Controls/Personal Protection
Engineering Controls Use process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below
recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to
airborne contaminants below the exposure limit.
Personal Protection Face shield. Lab coat. Dust respirator. Boots. Gloves. A MSHA/NIOSH approved respirator must be used to avoid
inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling
this product.
Exposure Limits Not available.

---

Section IX. Physical and Chemical Properties
Solubility
Physical state @ 20°C Solid. (White-Reddish-Yellow Crystalline Slightly soluble in toluene.
Powder.)
Not available.
Specific Gravity
Molecular Weight 254.73 Partition Coefficient Not available.
Boiling Point Not available. Vapor Pressure Not applicable.
Melting Point 50°C (122°F) Vapor Density Not available.
Refractive Index Not available. Volatility Not available.
Critical Temperature Not available. Odor Not available.
Viscosity Not available. Taste Not available.

---

Section X. Stability and Reactivity Data
Stability

---

This material is stable if stored under proper conditions. (See Section VII for instructions)
Conditions of Instability Avoid excessive heat and light.
Incompatibilities Reactive with oxidizing agents, alkalis (bases), water, alcohols.

---

Section XI. Toxicological Information
Not available.
RTECS Number
Eye Contact. Ingestion. Inhalation. Skin contact.
Routes of Exposure
Toxicity Data Not available.
Chronic Toxic Effects CARCINOGENIC EFFECTS : Not available.
MUTAGENIC EFFECTS : Not available.
TERATOGENIC EFFECTS : Not available.
DEVELOPMENTAL TOXICITY: Not available.
Repeated exposure of the eyes to a low level of dust can produce eye irritation. Repeated skin exposure can produce
local skin destruction, or dermatitis. Repeated inhalation of dust can produce varying degree of respiratory irritation or
lung damage.
Acute Toxic Effects Corrosive to skin, eyes, and respiratory system. Liquid or spray mist may produce tissue damage, particularly in mucous
membranes of the eyes, mouth and respiratory tract. Skin contact may produce burns. Eye contact can result in corneal
damage or blindness. Inhalation of the spray mist may produce severe irritation of respiratory tract, characterized by
coughing, choking, or shortness of breath. Corrosive materials may cause serious injury if ingested.
Harmful if ingested or inhaled. Minimize exposure to this material. Severe overexposure can result in injury or death.
Follow safe industrial hygiene practices and always wear proper protective equipment when handling this compound.
Continued on Next Page
2-(1-Naphthyl)ethanesulfonyl Chloride

---

Section XII. Ecological Information
Ecotoxicity Not available.
Not available.
Environmental Fate

---

Section XIII. Disposal Considerations
Recycle to process, if possible. Consult your local regional authorities. You may be able to dissolve or mix material with a
Waste Disposal
combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber system. Observe all
federal, state and local regulations when disposing of the substance.

---

Section XIV. Transport Information
DOT Classification DOT Class 8: Corrosive material.
PIN Number
Proper Shipping Name
Corrosive solid, acidic, organic, n.o.s.
Packing Group (PG) II
DOT Pictograms

---

Section XV. Other Regulatory Information and Pictograms
TSCA Chemical Inventory This product is NOT on the EPA Toxic Substances Control Act (TSCA) inventory. The following notices are required by 40
CFR 720.36 (C) for those products not on the inventory list:
(EPA)
(i) These products are supplied solely for use in research and development by or under the supervision of a technically
qualified individual as defined in 40 CFR 720.0 et sec.
(ii) The health risks of these products have not been fully determined. Any information that is or becomes available will be
supplied on an MSDS sheet.
WHMIS Classification CLASS E: Corrosive solid.
(Canada)
EINECS Number (EEC) Not available.
EEC Risk Statements R20/21/22- Harmful by inhalation, in contact with skin and if swallowed.
R34- Causes burns.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-(1-萘基)乙烷磺酰氯 在 四氯化碳 、 N-溴代丁二酰亚胺(NBS) 、 三氯化铝 、 硝基苯 、 过氧化苯甲酰 作用下， 生成 naphtho[2,1-b]thiophene-3,3-dioxide
  参考文献：
  名称：

  514.噻吩衍生物的聚合。第五部分：4：5-和6：7-苯并硫代环烷1：1-二氧化物的自缩合。合成1-1'和4-2'-萘菲的新途径

  摘要：

  DOI：

  10.1039/jr9560002609

文献信息

• Pyrrolidine derivatives
  申请人：——

  公开号：US20020049243A1

  公开（公告）日：2002-04-25

  The present invention relates to pyrrolidine derivatives and dimeric forms and/or pharmaceutically acceptable esters, and/or salts thereof. The compounds are useful as inhibitors of metalloproteases, e.g. zinc proteases, particularly zinc hydrolases, and which are effective in treating disease states are associated with vasoconstriction of increasing occurrences.

  本发明涉及吡咯烷衍生物及其二聚体形式和/或药用可接受的酯和/或盐。这些化合物可用作金属蛋白酶抑制剂，例如锌蛋白酶，特别是锌水解酶，对治疗与血管收缩增加发生相关的疾病状态有效。
• NOVEL SUBSTITUTED OCTAHYDROCYCLOPENTA[C]PYRROL-4-AMINES AS CALCIUM CHANNEL BLOCKERS
  申请人：Stewart Andrew O.

  公开号：US20100130558A1

  公开（公告）日：2010-05-27

  The present application relates to calcium channel inhibitors containing compounds of formula (I) wherein L 1 , L 2 , R 1 , R 2 , and R 3 are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.

  本申请涉及含有式（I）化合物的钙通道抑制剂，其中L1、L2、R1、R2和R3如规范中所定义。本申请还涉及包含这种化合物的组合物，以及使用这种化合物和组合物治疗疾病和疾病的方法。
• [EN] SULPHONYLAMINO DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE<br/>[FR] DERIVES SULFONYLAMINO POUR LE TRAITEMENT DE LA MALADIE D'ALZHEIMER
  申请人：NOVO PHARMACEUTICALS LTD DE

  公开号：WO2004020402A1

  公开（公告）日：2004-03-11

  A compound of formula (I), wherein R1 is alkyl, alkenyl, cycloalkyl, cycloalkenyl, heterocycloalkyl, heterocycloalkenyl, aryl, heteroaryl, heteropolycyclyl or polycyclyl, any of which is optionally substituted with alkyl, heteroaryl, aryl or -O-aryl; R2 is alkyl, alkenyl or aryl, any of which is optionally substituted with hydroxy, halogen, aryl, heteroaryl, cycloalkyl, cycloalkenyl, -C(O)NH-aryl, heterocycloalkyl, heterocycloalkenyl, heteropolycyclyl or polycyclyl; R3 is hydrogen or aryl; R4 is alkyl, alkenyl, alkoxy, alkylthio or aryl, any of which is optionally substituted with hydroxy, aryl, heteroaryl, cycloalkyl, cycloalkenyl, thioalkyl, heterocycloalkyl, heterocycloalkenyl, heteropolycyclyl or polycyclyl; R5 is hydrogen or an alkyl or alkenyl group optionally substituted with hydroxy, aryl, -C(O)O- alkyl or -C(O)NH- alkyl; or R4-C-R5 taken together form cycloalkyl, cycloalkenyl or polycyclyl, any of which is optionally substituted with alkyl or hydroxyalkyl; R6 is hydrogen, alkyl, -alkyl-aryl or -alkyl-heteroaryl; or a pharmaceutically-acceptable salt thereof.

  公式(I)的化合物，其中R1是烷基、烯基、环烷基、环烯基、杂环烷基、杂环烯基、芳基、杂芳基、杂多环烷基或多环烷基，任选地被烷基、杂芳基、芳基或-O-芳基取代；R2是烷基、烯基或芳基，任选地被羟基、卤素、芳基、杂芳基、环烷基、环烯基、-C(O)NH-芳基、杂环烷基、杂环烯基、杂多环烷基或多环烷基取代；R3是氢或芳基；R4是烷基、烯基、烷氧基、硫代烷基或芳基，任选地被羟基、芳基、杂芳基、环烷基、环烯基、硫代烷基、杂环烷基、杂环烯基、杂多环烷基或多环烷基取代；R5是氢或烷基或烯基，任选地被羟基、芳基、-C(O)O-烷基或-C(O)NH-烷基取代；或者R4-C-R5共同形成环烷基、环烯基或多环烷基，任选地被烷基或羟基烷基取代；R6是氢、烷基、-烷基-芳基或-烷基-杂芳基；或其药物可接受的盐。
• ASYMMETRIC CATALYST AND PROCESS FOR PREPARING OPTICALLY ACTIVE ALCOHOLS USING THE SAME
  申请人：Watanabe Masahito

  公开号：US20100261924A1

  公开（公告）日：2010-10-14

  The present invention provides an organic metal compound, a ligand, an asymmetric catalyst, and a process for preparing optically-active alcohols using the asymmetric catalyst. The organic metal compound of the present invention is expressed by the following general formula (1): wherein in general formula (1), R 1 and R 2 are a mutually identical or mutually different, unsubstituted or substituted alkyl group, aryl group, cycloalkyl group, or R 1 and R 2 are bound to form an alicyclic ring, R 3 is a hydrogen atom or an alkyl group, R 4 is a branched alkyl group or an alkyl group that does or does not form a ring by itself, or an unsubstituted or substituted aryl group, or an unsubstituted or substituted heterocyclic group, Ar is an unsubstituted or substituted cyclopentadienyl group that is bound to M via a π bond, or an unsubstituted or substituted benzene, X is a hydride group or an anionic group, M is ruthenium, rhodium or iridium, L is a solvent molecule or a water molecule, l is 1 or 2, m is an integer from 0 to 2, n is 0 or 1, and when n is 0, X does not exist, and * represents asymmetric carbon, wherein R 4 is not a camphor group, a camphor derivative group, an isopropyl group or a phenyl group whenever R 1 and R 2 are both a phenyl group.

  本发明提供一种有机金属化合物、配体、不对称催化剂以及利用该不对称催化剂制备光学活性醇的方法。本发明的有机金属化合物由以下通用式（1）表示： 在通用式（1）中，R1和R2是相互相同或相互不同的未取代或取代的烷基基团、芳基团、环烷基团，或R1和R2结合形成脂环，R3是氢原子或烷基基团，R4是支链烷基基团或自身形成环或不形成环的烷基基团，或未取代或取代的芳基团，或未取代或取代的杂环基团，Ar是通过π键与M结合的未取代或取代的环戊二烯基团，或未取代或取代的苯，X是氢化物基团或阴离子基团，M是钌、铑或铱，L是溶剂分子或水分子，l为1或2，m为0到2的整数，n为0或1，当n为0时，X不存在，*代表不对称碳，其中当R1和R2均为苯基团时，R4不是藿香基团、藿香衍生基团、异丙基团或苯基团。
• Identification and use of protease inhibitors
  申请人：ELI LILLY AND COMPANY

  公开号：EP0652009A1

  公开（公告）日：1995-05-10

  β-amyloid peptide (βAF) production in cell culture and in vivo is inhibited by administering aspartyl protease inhibitors, particularly inhibitors of proteases of cathepsin D. Useful aspartyl protease inhibitors can be selected in a two-step assay, where test compounds are first screened for aspartyl protease inhibition activity in vitro in noncellular assays. Those test compounds which are found to display protease inhibition activity are then tested in cellular assays for βAP production inhibition. Those test compounds which are capable of inhibiting intracellular β-amyloid production may be incorporated in pharmaceutical compositions.

  β-淀粉样蛋白（βAF）在细胞培养和体内的产生受到阻断，通过给予天冬氨酸蛋白酶抑制剂，特别是半胱氨酸蛋白酶D的抑制剂。有用的天冬氨酸蛋白酶抑制剂可以在两步法测定中选择，其中首先在非细胞试验中筛选测试化合物是否具有体外天冬氨酸蛋白酶抑制活性。那些被发现具有蛋白酶抑制活性的测试化合物随后在细胞试验中进行βAP产生抑制的测试。那些能够抑制细胞内β-淀粉样蛋白产生的测试化合物可以被纳入药物组合物中。